Drawing for VATIC

USPTO serial 90324658

VATIC

Reviewed by CopyMark Law Group

Reg. 6669569Status 700Registered
Filing date
Status date
Registration date
Mar 15, 2022
Examiner
ALLEN, BIANCA LEIGH
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with VATIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark H. Tidman

Mark H. Tidman BAKER & HOSTETLER LLP1050 CONNECTICUT AVENUE NWWASHINGTON SQUARE, SUITE 1100WASHINGTON, DC 20036-5304

Goods and services

ClassDescriptionStatusFirst use
005Medical testing kits primarily containing reagents for medical use and also containing a protocol in the nature of an instruction manual, the kits being for medical purposes and medical diagnostics; medical testing kits comprised primarily of reagents for medical use, enzymes for medical purposes, medical diagnostic agents, medical diagnostic assays, buffers, chemical preparations for medical purposes, biological preparations for medical purposes, and nucleotides, all for medical genetic testing and medical diagnostic purposes; medical diagnostic agents, reagents for medical use, medical diagnostic assays, enzymes for medical purposes, nucleotides being medical diagnostic agents, buffers in the nature of liquid stabilizers for use in medical diagnostic testing, buffers in the nature of extraction buffers for testing body fluids, chemical preparations for medical purposes, and biological preparations, all for medical use for testing body fluids, and all in the fields of medical diagnostics, clinical diagnostics, laboratory medicine, medicine, genetic testing, and geneticsACTIVE
009Downloadable computer software for clinical diagnostics; downloadable computer software to detect antibodies, antigens, pathogens and viruses in a genetic sample; downloadable computer software for medical diagnostic testing; downloadable mobile applications to detect and monitor inflammatory responses; downloadable mobile applications to detect and monitor antibodies, antigens, pathogens and viruses; downloadable computer software used in the field of medical research, life sciences, biology, microbiology, biotechnology and genetics, namely, software for medical diagnostics; downloadable mobile applications to monitor autoimmune diseasesACTIVE
010Testing medical diagnostic apparatus to detect inflammatory response; medical diagnostic apparatus for use in detecting antibodies, antigens, pathogens, viruses; Medical diagnostic apparatus and instruments for the analysis of body fluids, including blood and saliva; Apparatus for blood analysis; Analytical apparatus for medical purposes for diagnosing or treating respiratory diseases; medical diagnostic apparatus to detect and monitor autoimmune responses; Apparatus for DNA and RNA testing for medical purposes; Medical apparatus and instruments for diagnosing or treating respiratory diseases; apparatus for medical purposes, namely, for diagnosing or treating respiratory diseases; Clinical and medical apparatus and instruments, namely, for diagnosing or treating respiratory diseases; Clinical and medical apparatus and instruments, namely, nucleic acid array scanners for medical purposes, medical imaging devices for the eyes, nose, throat, respiratory tract, lungs and the human body, and polymerase chain reaction analysers being medical diagnostic instrumentsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 23, 2022ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 15, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 9, 2022ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Dec 28, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 28, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 8, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 22, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 12, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 12, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 8, 2021ALIEASSIGNED TO LIE
Nov 2, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 3, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 3, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 3, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 28, 2021DOCKASSIGNED TO EXAMINER
Jan 17, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 20, 2020NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance